Ebrahimi, E. and Shirkoohi, R. (2018) “What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?”, Archives of Breast Cancer, pp. 148-149. doi: 10.32768/abc.201854148-149.